Spots Global Cancer Trial Database for mitoxantrone hydrochloride liposome injection
Every month we try and update this database with for mitoxantrone hydrochloride liposome injection cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| The Efficacy and Safety of the RCMOP Sequential Therapy as a First-line Treatment for Patients With Intermediate-to-high Risk Diffuse Large B-cell Lymphoma Who Had Incomplete Remission. | NCT05990985 | Diffuse Large B... | Mitoxantrone hy... RiTUXimab Injec... Cyclophosphamid Vincristine Prednisolone | 18 Years - | The First Hospital of Jilin University | |
| A Study of Mitoxantrone Hydrochloride Liposome Injection in Chinese Patients With Advanced Solid Tumors | NCT04921878 | Advanced Solid ... | Mitoxantrone Hy... | 18 Years - 65 Years | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | |
| A Study of Mitoxantrone Hydrochloride Liposome Injection Combination Therapy in Chinese Patients With Advanced Solid Tumors | NCT05344742 | Advanced Solid ... | Mitoxantrone Hy... Capecitabine Albumin-paclita... | 18 Years - 65 Years | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | |
| Mitoxantrone Hydrochloride Liposome Injection, Bortezomib and Dexamethasone in the Treatment of R/R MM | NCT05052970 | Relapsed or Ref... | Mitoxantrone Hy... Bortezomib for ... Dexamethasone A... | 18 Years - 75 Years | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | |
| A Study to Evaluate the Tolerance and Efficacy of Mitoxantrone Hydrochloride Liposome Injection Combined With Cytarabine in Patients With Acute Myeloid Leukemia (AML) | NCT05100303 | Treatment-naive... | Mitoxantrone Hy... Cytarabine (LoD... | 18 Years - | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | |
| Mitoxantrone Hydrochloride Liposome Injection in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | NCT05875428 | Diffuse Large B... | Mitoxantrone Hy... | 18 Years - | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | |
| Mitoxantrone Hydrochloride Liposome Injection, Bortezomib and Dexamethasone in the Treatment of R/R MM | NCT05052970 | Relapsed or Ref... | Mitoxantrone Hy... Bortezomib for ... Dexamethasone A... | 18 Years - 75 Years | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | |
| A Study of Mitoxantrone Hydrochloride Liposome Injection in Advanced Recurrent or Metastatic Breast Cancer | NCT02596373 | Advanced Recurr... | Mitoxantrone Hy... | 18 Years - 75 Years | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | |
| Mitoxantrone Hydrochloride Liposome Injection in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | NCT05875428 | Diffuse Large B... | Mitoxantrone Hy... | 18 Years - | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | |
| A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced Pancreatic Cancer | NCT05100329 | Advanced Pancre... | Mitoxantrone Hy... | 18 Years - 75 Years | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | |
| Phase I and Pharmacokinetic Study of Mitoxantrone Hydrochloride Liposome Injection | NCT02043756 | Neoplasms | Mitoxantrone Hy... Mitoxantrone | 18 Years - 70 Years | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | |
| A Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Advanced Bone and Soft Tissue Sarcoma | NCT04900766 | Unresectable or... | Mitoxantrone Hy... | 18 Years - | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | |
| A Study of Mitoxantrone Hydrochloride Liposome Injection in Patients With Advanced Pancreatic Cancer | NCT05100329 | Advanced Pancre... | Mitoxantrone Hy... | 18 Years - 75 Years | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | |
| A Study to Evaluate the Tolerance and Efficacy of Mitoxantrone Hydrochloride Liposome Injection Combined With Cytarabine in Patients With Acute Myeloid Leukemia (AML) | NCT05100303 | Treatment-naive... | Mitoxantrone Hy... Cytarabine (LoD... | 18 Years - | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
